In the latest data point for Q1'26, AbbVie reported a Gross Margin of 71.9%, an Operating Margin of 26.6%, and a Net Profit Margin of 4.6%. These figures reflect a slight decline in profitability compared to the previous quarter, particularly in the net margin, following a stronger Q4'25 performance. From Q2'23 to Q1'26, the company's Profit Margin has exhibited significant volatility, marked by a notable low in Q4'24 where the Operating Margin dropped to -9.87% and the Net Profit Margin fell to -0.1%. While the Gross Margin has remained relatively stable and generally trended upward from a low of 53.4% in Q3'23 to over 70% in recent periods, the operating and net margins have seen sharper fluctuations due to non-operating costs or periodic expenses. Despite these swings, the long-term trend shows a recovery from the fiscal 2024 lows, though profitability remains sensitive to quarterly operational shifts.